Home > Insider Trading > Filing (0001209191-19-054164)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087294	Cumberland Pharmaceuticals Inc	CPIX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1632384	C Joseph Galante	2525 West End Avenue Suite 950 Nashville TN 37203		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-09-20	60	$5.33	15,578	No	4	P	Direct
Common Stock	Acquisiton	2019-09-23	60	$5.35	15,638	No	4	P	Direct
Common Stock	Acquisiton	2019-09-24	60	$5.39	15,698	No	4	P	Direct
Common Stock	Acquisiton	2019-09-25	60	$5.38	15,758	No	4	P	Direct
Common Stock	Acquisiton	2019-09-26	60	$5.76	15,818	No	4	P	Direct
Common Stock	Acquisiton	2019-09-27	60	$5.76	15,878	No	4	P	Direct
Common Stock	Acquisiton	2019-09-30	60	$5.89	15,938	No	4	P	Direct
Common Stock	Acquisiton	2019-10-01	60	$5.89	15,998	No	4	P	Direct
Common Stock	Acquisiton	2019-10-02	60	$5.77	16,058	No	4	P	Direct
Common Stock	Acquisiton	2019-10-04	60	$5.76	16,118	No	4	P	Direct
Common Stock	Acquisiton	2019-10-07	60	$5.74	16,178	No	4	P	Direct
Common Stock	Acquisiton	2019-10-08	60	$5.81	16,238	No	4	P	Direct
Common Stock	Acquisiton	2019-10-09	60	$5.78	16,298	No	4	P	Direct
Common Stock	Acquisiton	2019-10-10	60	$5.86	16,358	No	4	P	Direct
Common Stock	Acquisiton	2019-10-11	60	$5.71	16,418	No	4	P	Direct
Common Stock	Acquisiton	2019-10-14	60	$5.67	16,478	No	4	P	Direct
Common Stock	Acquisiton	2019-10-15	60	$5.63	16,538	No	4	P	Direct
Common Stock	Acquisiton	2019-10-16	60	$5.56	16,598	No	4	P	Direct
Common Stock	Acquisiton	2019-10-17	60	$5.52	16,658	No	4	P	Direct
Common Stock	Acquisiton	2019-10-18	34	$5.45	16,692	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.